BANK OF AMERICA CORP /DE/ - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$53,602
-53.1%
20,537
-35.6%
0.00%
Q2 2023$114,241
-8.5%
31,911
-44.3%
0.00%
Q1 2023$124,884
-44.9%
57,286
+203.8%
0.00%
Q4 2022$226,850
+39.2%
18,857
-24.8%
0.00%
Q3 2022$163,000
-10.4%
25,077
-36.9%
0.00%
Q2 2022$182,000
-70.2%
39,737
-43.7%
0.00%
Q1 2022$611,000
-48.8%
70,611
-15.5%
0.00%
Q4 2021$1,194,000
+137.8%
83,530
+266.2%
0.00%
Q3 2021$502,000
+90.9%
22,813
+16.4%
0.00%
Q2 2021$263,000
+47.8%
19,604
+11.6%
0.00%
Q1 2021$178,000
+212.3%
17,569
+29.9%
0.00%
Q4 2020$57,000
+2750.0%
13,521
+1831.6%
0.00%
Q3 2020$2,0000.0%7000.0%0.00%
Q2 2020$2,0000.0%700
-5.8%
0.00%
Q1 2020$2,000
-66.7%
743
-33.5%
0.00%
Q4 2019$6,000
+50.0%
1,1170.0%0.00%
Q3 2019$4,0000.0%1,117
-9.6%
0.00%
Q2 2019$4,0000.0%1,236
+10.7%
0.00%
Q1 2019$4,000
+33.3%
1,1170.0%0.00%
Q4 2018$3,000
-40.0%
1,1170.0%0.00%
Q3 2018$5,000
-37.5%
1,1170.0%0.00%
Q2 2018$8,000
+14.3%
1,1170.0%0.00%
Q1 2018$7,000
-30.0%
1,1170.0%0.00%
Q4 2017$10,000
-9.1%
1,1170.0%0.00%
Q3 2017$11,000
+22.2%
1,1170.0%0.00%
Q2 2017$9,000
+28.6%
1,1170.0%0.00%
Q1 2017$7,000
+16.7%
1,117
+21.8%
0.00%
Q4 2016$6,000
+50.0%
917
+77.4%
0.00%
Q3 2016$4,000
+300.0%
517
+417.0%
0.00%
Q2 2016$1,0000.0%1000.0%0.00%
Q1 2016$1,0000.0%1000.0%0.00%
Q4 2015$1,000
-96.4%
100
-98.0%
0.00%
Q3 2015$28,000
+2700.0%
5,100
+5000.0%
0.00%
Q2 2015$1,0000.0%1000.0%0.00%
Q1 2015$1,0001000.0%0.00%
Q4 2014$0
-100.0%
100
-96.7%
0.00%
Q2 2014$29,000
-58.6%
3,000
-50.0%
0.00%
Q1 2014$70,0006,0000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders